Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 16 X users

Citations

dimensions_citation: 176 Dimensions

Readers on

mendeley: 176 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 17 X posts from 16 X users, with an upper bound of 32,317 followers.

You can read the full article here: https://t.co/f3IHLneKlD Video from: https://t.co/iD78aQ65GI

21 Sep 2022

Reply Repost Favourite

Management in case reports includes steroids, IVIg and plasma exchange. More here: https://t.co/f7RAmpEwsZ and https://t.co/s3wSL5nVcy 15/

14 Sep 2022

Reply Repost Favourite

#Autoimmune

20 Jun 2022

Reply Repost Favourite

Did you know that Myasthenia Gravis, an autoimmune disorder, can be a rare, but life-threatening event for patients who receive IL-1 checkpoint inhibitors? It usually presents within 4 weeks of infusion. PLEX is used to treat. Review of the literature 👉🏽

20 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 13 additional X posts.